Showing top 20 of 102 holdings— Unlock all holdings
#Ticker Name Weight Shares Mkt Value Share ChgSectorIndustry
1GILDGilead Sciences Inc6.44%--••••••••••••••••••••••
2AMGNAmgen Inc5.97%--••••••••••••••••••••••
3REGNRegeneron Pharmaceuticals Inc5.91%--••••••••••••••••••••••
4VRTXVertex Pharmaceuticals Inc3.96%--••••••••••••••••••••••
5LLYEli Lilly & Co3.57%--••••••••••••••••••••••
6BMRNBioMarin Pharmaceutical Inc2.92%--••••••••••••••••••••••
7ALNYAlnylam Pharmaceuticals Inc2.77%--••••••••••••••••••••••
8UNHUnitedHealth Group Inc2.77%--••••••••••••••••••••••
9GVMXXState Street Global Advisors2.23%--••••••••••••••••••••••
10ABTAbbott Laboratories2.05%--••••••••••••••••••••••
11BNTXBioNTech SE2.02%--••••••••••••••••••••••
12ARGXArgenx SE1.84%--••••••••••••••••••••••
13SRPTSarepta Therapeutics Inc1.81%--••••••••••••••••••••••
14SMMTSummit Therapeutics Inc1.70%--••••••••••••••••••••••
15IM8NInsmed Inc1.69%--••••••••••••••••••••••
16ABBVAbbVie Inc1.63%--••••••••••••••••••••••
17ASNDAscendis Pharma A/S1.48%--••••••••••••••••••••••
18TMOThermo Fisher Scientific Inc1.41%--••••••••••••••••••••••
19MDTMedtronic PLC1.33%--••••••••••••••••••••••
20NBIXNeurocrine Biosciences Inc1.33%--••••••••••••••••••••••
82+ more holdings available
See all 102 holdings with sector, industry, share changes & CSV export
Unlock All Holdings — $149 $60/mo
Limited to first 500 subscribers - Cancel anytime

HQH ETF All Holdings

HQH holdings total 102 positions. The top 10 holdings account for 38.6% of the fund, led by Gilead Sciences Inc at 6.4%, Amgen Inc at 6.0%, Regeneron Pharmaceuticals Inc at 5.9%.

HQH portfolio concentration is moderate, with the top 10 representing 38.6% of total assets. The largest sector exposure is Unknown at 91.6%.

HQH sector allocation provides a detailed breakdown. HQH overlap tool shows how holdings compare to other funds in your portfolio.

HQH ETF Holdings

102 of 102 holdings

  • 1

    Gilead Sciences Inc

    GILDUnknown
    6.44%
  • 2

    Amgen Inc

    AMGNUnknown
    5.97%
  • 3

    Regeneron Pharmaceuticals Inc

    REGNUnknown
    5.91%
  • 4

    Vertex Pharmaceuticals Inc

    VRTXUnknown
    3.96%
  • 5

    Eli Lilly & Co

    LLYUnknown
    3.57%
  • 6

    BioMarin Pharmaceutical Inc

    BMRNUnknown
    2.92%
  • 7

    Alnylam Pharmaceuticals Inc

    ALNYUnknown
    2.77%
  • 8

    UnitedHealth Group Inc

    UNHUnknown
    2.77%
  • 9

    State Street Global Advisors

    GVMXXUnknown
    2.23%
  • 10

    Abbott Laboratories

    ABTUnknown
    2.05%
  • 11

    BioNTech SE

    BNTXUnknown
    2.02%
  • 12

    Argenx SE

    ARGXUnknown
    1.84%
  • 13

    Sarepta Therapeutics Inc

    SRPTUnknown
    1.81%
  • 14

    Summit Therapeutics Inc

    SMMTUnknown
    1.70%
  • 15

    Insmed Inc

    IM8NUnknown
    1.69%
  • 16

    AbbVie Inc

    ABBVUnknown
    1.63%
  • 17

    Ascendis Pharma A/S

    ASNDUnknown
    1.48%
  • 18

    Thermo Fisher Scientific Inc

    TMOUnknown
    1.41%
  • 19

    Medtronic PLC

    MDTUnknown
    1.33%
  • 20

    Neurocrine Biosciences Inc

    NBIXUnknown
    1.33%
  • 21

    Intuitive Surgical Inc

    ISRGUnknown
    1.24%
  • 22

    Cytokinetics Inc

    CYTKUnknown
    1.21%
  • 23

    Merck & Co Inc

    MRKUnknown
    1.20%
  • 24

    Illumina Inc

    ILMNUnknown
    1.19%
  • 25

    uniQure NV

    QUREUnknown
    1.18%
  • 26

    Ultragenyx Pharmaceutical Inc

    RAREUnknown
    1.13%
  • 27

    Becton Dickinson & Co

    BDXUnknown
    1.12%
  • 28

    Elevance Health Inc

    ELVUnknown
    1.05%
  • 29

    Immunovant Inc

    IMVTUnknown
    1.00%
  • 30

    AstraZeneca PLC

    AZNUnknown
    0.99%
  • 31

    Akero Therapeutics Inc

    AKROUnknown
    0.93%
  • 32

    Tempus AI Inc

    TEMUnknown
    0.86%
  • 33

    Xenon Pharmaceuticals Inc

    XENEUnknown
    0.85%
  • 34

    Ionis Pharmaceuticals Inc

    ISIUnknown
    0.84%
  • 35

    Oculis Holding AG

    OCSUnknown
    0.81%
  • 36

    Zoetis Inc

    ZTSUnknown
    0.79%
  • 37

    Inspire Medical Systems Inc

    INSPUnknown
    0.76%
  • 38

    Arrowhead Pharmaceuticals Inc

    ARWRUnknown
    0.69%
  • 39

    Arcutis Biotherapeutics Inc

    ARQTUnknown
    0.65%
  • 40

    Amylyx Pharmaceuticals Inc

    AMLXUnknown
    0.63%
  • 41

    Denali Therapeutics Inc

    DNLIUnknown
    0.60%
  • 42

    Vaxcyte Inc

    PCVXUnknown
    0.59%
  • 43

    Bristol-Myers Squibb Co

    BMYUnknown
    0.58%
  • 44

    Guardant Health Inc

    GHUnknown
    0.58%
  • 45

    ARS Pharmaceuticals Inc

    SPRYUnknown
    0.57%
  • 46

    Sionna Therapeutics Inc

    SIONUnknown
    0.57%
  • 47

    GRAIL Inc

    GRALUnknown
    0.53%
  • 48

    HCA Healthcare Inc

    HCAUnknown
    0.53%
  • 49

    Travere Therapeutics Inc

    TVTXUnknown
    0.52%
  • 50

    Molina Healthcare Inc

    MOHUnknown
    0.52%
  • 51

    Tenet Healthcare Corp

    THCUnknown
    0.51%
  • 52

    Adaptive Biotechnologies Corp

    ADPTUnknown
    0.50%
  • 53

    Ideaya Biosciences Inc

    IDYAUnknown
    0.49%
  • 54

    Medpace Holdings Inc

    MEDPUnknown
    0.49%
  • 55

    Krystal Biotech Inc

    KRYSUnknown
    0.47%
  • 56

    Dexcom Inc

    DC4Unknown
    0.47%
  • 57

    Edgewise Therapeutics Inc

    EWTXUnknown
    0.45%
  • 58

    Halozyme Therapeutics Inc

    HALOUnknown
    0.45%
  • 59

    Danaher Corp

    DHRUnknown
    0.45%
  • 60

    Avidity Biosciences Inc

    RNAUnknown
    0.44%
  • 61

    Janux Therapeutics Inc

    JANXUnknown
    0.44%
  • 62

    Axsome Therapeutics Inc

    AXSMUnknown
    0.42%
  • 63

    Crinetics Pharmaceuticals Inc

    CRNXUnknown
    0.41%
  • 64

    Rhythm Pharmaceuticals Inc

    RYTMUnknown
    0.40%
  • 65

    Geron Corp

    GONUnknown
    0.39%
  • 66

    Teva Pharmaceutical Industries Ltd

    TEVAUnknown
    0.38%
  • 67

    Boston Scientific Corp

    BSXUnknown
    0.35%
  • 68

    Tandem Diabetes Care Inc

    TNDMUnknown
    0.34%
  • 69

    Nuvalent Inc

    NUVLUnknown
    0.32%
  • 70

    Alkermes PLC

    ALKSUnknown
    0.31%
  • 71

    Vir Biotechnology Inc

    VIRUnknown
    0.30%
  • 72

    Personalis Inc

    PSNLUnknown
    0.28%
  • 73

    Incyte Corp

    INCYUnknown
    0.27%
  • 74

    Newamsterdam Pharma Co NV

    NAMSUnknown
    0.26%
  • 75

    Merus NV

    MRUSUnknown
    0.25%
  • 76

    McKesson Corp

    MCKUnknown
    0.24%
  • 77

    Praxis Precision Medicines Inc

    PRAXUnknown
    0.24%
  • 78

    Stryker Corp

    SYKUnknown
    0.23%
  • 79

    Sera Prognostics Inc

    SERAUnknown
    0.23%
  • 80

    Xencor Inc

    XNCRUnknown
    0.21%
  • 81

    Structure Therapeutics Inc

    GPCRUnknown
    0.21%
  • 82

    Scholar Rock Holding Corp

    SRRKUnknown
    0.20%
  • 83

    Cidara Therapeutics Inc

    CDTXUnknown
    0.19%
  • 84

    Insulet Corp

    PODDUnknown
    0.13%
  • 85

    EyePoint Pharmaceuticals Inc

    EYPTUnknown
    0.09%
  • 86

    TScan Therapeutics Inc

    TCRXUnknown
    0.07%
  • 87

    Pyxis Oncology Inc

    PYXSUnknown
    0.06%
  • 88

    Rallybio Corp

    RLYBUnknown
    0.05%
  • 89

    Novavax Inc

    NVV1Unknown
    0.03%
  • 90

    CONTRA CHINOOK THERAPE

    Unknown
    0.02%
  • 91

    169CVR016

    169CVR016Unknown
    0.02%
  • 92

    Sutro Biopharma Inc

    STROUnknown
    0.00%
  • 93

    I-Mab

    IMABUnknown
    0.00%
  • 94

    Mural Oncology PLC

    MURAUnknown
    0.00%
  • 95

    CONTRA FUSION PHARMACE

    Unknown
    0.00%
  • 96

    361CVR012

    361CVR012Unknown
    0.00%
  • 97

    Galera Therapeutics Inc

    GRTXUnknown
    0.00%
  • 98

    881CVR013

    881CVR013Unknown
    0.00%
  • 99

    TETRAPHASE PHARMACEUTICALS INC

    Unknown
    0.00%
  • 100

    CONTRA SPECTRUM PHARMA

    Unknown
    0.00%
  • 101

    847CVR016

    847CVR016Unknown
    0.00%
  • 102

    000000000

    000000000Unknown
    -0.00%